Figure 4.
Sunitinib stimulated CD146 expression in patients treated with sunitinib in a neoadjuvant setting. Tumors from untreated ccRCC patients and tumors from patients treated with sunitinib in a neoadjuvant setting were compared (see Table S3). The levels of CD146 total (short + long form, A), CD146 long (B), CD146 short (C) and angiomotin (D) mRNA were determined by qPCR.